Overview of Biomarker-Selected Immune Checkpoint Blockade in Lung Cancer

In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for ALL

Renier J. Brentjens, MD, PhD Released: December 3, 2020

In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for lymphomas

Frederick L. Locke, MD Released: December 3, 2020

In this slideset from Clinical Care Options, experts provide insights on emerging CAR T-cell strategies for myeloma.

Noopur Raje, MD Released: December 3, 2020

Download this brief slideset for a review of the latest clinical data informing optimal treatment of relapsed ES-SCLC, from Clinical Care Options (CCO)

Benjamin Levy, MD Released: December 1, 2020